货号:GS40684
Suvemcitug is a recombinant humanized IgG1 kappa monoclonal antibody targeting vascular endothelial growth factor A (VEGF-A). It binds to VEGF-A to block its interaction with VEGF receptors (VEGFR-1 and VEGFR-2), thereby inhibiting angiogenesis and vascular leakage. It is being developed for the treatment of neovascular age-related macular degeneration (nAMD) and other retinal vascular diseases.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物